Insiders Biohit Oyj

Equities

Market Closed - Nasdaq Helsinki Other stock markets 16:07:23 07/05/2024 BST			5-day change	1st Jan Change
2 ^EUR	0.00%		-0.50%	+6.10%

04-15	Faron Pharmaceuticals reappoints former finance chief on interim basis	AN
02-14	Biohit Oyj Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Faron Pharmaceuticals reappoints former finance chief on interim basis	04-15	AN
Biohit Names New Chief Commercial Officer	11-22	MT
Biohit Oyj Announces Changes in the Management Group	11-22	CI
Biohit Oyj Elects Vesa Silaskivi as Chairman of the Board of Directors	15/06/23	CI
Biohit Oyj Approves Election of Vesa Silaskivi as Members of Board of Directors	14/06/23	CI
Biohit Oyj Announces Executive Changes	15/12/22	CI
Biohit Appoints New CFO	06/09/22	MT
Biohit Oyj Appoints Jussi Sorvo as Chief Financial Officer, Effective on September 7, 2022	06/09/22	CI
Biohit Oyj Appoints Jussi Sorvo as Member of the Management, Effective on September 7, 2022	06/09/22	CI
Finnish Biotech Biohit Appoints CFO as CEO	02/09/22	MT
Biohit Oyj Announces Executive Changes	02/09/22	CI
Biohit Oyj Appoints Lea Paloheimo as the Chairman of the Board of Directors	16/06/22	CI
Biohit Oyj Elects Kalle Härkönen as Board of Director	15/06/22	CI
Biohit Oyj Appoints MA Päivi Siltala as the CEO of the Company Starting September 1, 2021	29/07/21	CI
Biohit Oyj Elects Eero Lehti as the Chairman of the Board of Directors	29/06/21	CI
Biohit Oyj Announces Management Changes	28/06/21	CI
Biohit Oyj Appoints Jussi Hahtelala as Chief Financial Officer Starting June 4, 2021	24/05/21	CI
Biohit Oyj Appoints Jussi Hahtelala as Member of the Management Team Starting June 4, 2021	24/05/21	CI
Biohit Oyj's President and CEO Semi Korpela to Leave the Company	17/05/21	CI
Biohit Oyj's CEO Is on Sick Leave	26/03/21	CI

No results for this search